| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Highlights Healthcare is a company that provides diagnosis, early intervention, and ABA therapy services to bring meaningful and positive change to learners with Autism Spectrum Disorder.
Emerald Heights, sponsored by Emerald Communities, is a nonprofit 501(c)(3) senior housing and service organization that provides its residents programs to cultivate culture, vitality and independence. The community is a Type A Continuing Care Retirement Community (CCRC) that accommodates residents`changing needs throughout the aging process. Situated on 38 acres in the Education Hill area of Redmond, Wash., just 17 miles northeast of Seattle, Emerald Heights is an amenity-rich and resort-style senior living community, plus an assisted living facility and a Medicare-certified skilled nursing health center. The campus opened in 1992 to provide housing and service to people ages 55 and older in the aspects of independent, assisted living and skilled nursing.
Digestive Healthcare is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BetterNight’s platform integrates a comprehensive sleep apnea solution including screening, testing, telemedicine, therapy and remote patient monitoring. This comprehensive platform is unique in the market providing clients the opportunity to ...